Overview

Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis

Status:
Completed
Trial end date:
2017-07-18
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of firsocostat in adults with nonalcoholic steatohepatitis (NASH).
Phase:
Phase 2
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Firsocostat